Alx Oncology Holdings ALXO
NASDAQ ALXO
$2.01 -0.02 (-0.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026)

Alx Oncology Holdings (ALXO) posted Prepaid Assets of $295000.0 for Q1 2026, down 72.4% sequentially from $1.1 million in Q4 2025, and down 93.72% YoY from $4.7 million in Q1 2025.

Analysis

Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026) Analysis & Trends

Alx Oncology Holdings has reported Prepaid Assets for 8 years, with the latest figure at $295000.0 in Q1 2026.

  • Quarterly Prepaid Assets fell 93.72% year-over-year to $295000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $295000.0 (down 93.72% YoY) and the FY2025 annual result came in at $1.1 million, up 3859.26% from the prior year.
  • Prepaid Assets eased to $295000.0 in Q1 2026 per ALXO's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $10.4 million in Q1 2024 and troughed at $27000.0 in Q4 2024.
  • A 5-year average of $3.5 million and a median of $3.5 million in 2022 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets plunged 95.57% in 2024, then jumped 3859.26% in 2025.
  • Over 5 years, Prepaid Assets stood at $4.8 million in 2022, then plunged by 87.21% to $609000.0 in 2023, then tumbled by 95.57% to $27000.0 in 2024, then surged by 3859.26% to $1.1 million in 2025, then slumped by 72.4% to $295000.0 in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $295000.0, $1.1 million, and $892000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Alx Oncology Holdings 272.64 Mn 272.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.23 Mn
Mar 31, 2026 5.24 Mn
Dec 31, 2025 5.94 Mn
Sep 30, 2025 5.89 Mn
Jun 30, 2025 5.94 Mn
Mar 31, 2025 4.70 Mn
Dec 31, 2024 6.60 Mn
Sep 30, 2024 7.32 Mn
Jun 30, 2024 11.99 Mn
Mar 31, 2024 10.43 Mn
Dec 31, 2023 5.92 Mn
Sep 30, 2023 9.06 Mn
Jun 30, 2023 6.73 Mn
Mar 31, 2023 4.59 Mn
Dec 31, 2022 4.76 Mn
Sep 30, 2022 5.90 Mn
Jun 30, 2022 3.48 Mn
Mar 31, 2022 4.93 Mn
Dec 31, 2021 3.35 Mn
Sep 30, 2021 3.81 Mn